We are live on
!
Find out more
BC
Broadwater Capital Portfolio holdings
AUM
$138M
1-Year Est. Return
28.86%
This Fund
S&P 500
This Quarter
Est. Return
-1.62%
1 Year Est. Return
+28.86%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$131M
AUM Growth
-$5.16M
(-3.8%)
Cap. Flow
-$1.71M
Cap. Flow
% of AUM
-1.31%
Top 10 Holdings %
Top 10 Hldgs %
48.53%
Holding
241
New
3
Increased
5
Reduced
39
Closed
8
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan Chase
JPM
|
+$303K |
| 2 |
Vanguard S&P 500 ETF
VOO
|
+$10.8K |
| 3 |
TSMC
TSM
|
+$9.68K |
| 4 |
Vanguard Russell 2000 ETF
VTWO
|
+$9.23K |
| 5 |
Oracle
ORCL
|
+$178 |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CVS Health
CVS
|
+$312K |
| 2 |
AGR
Avangrid, Inc.
AGR
|
+$215K |
| 3 |
Johnson & Johnson
JNJ
|
+$212K |
| 4 |
Coca-Cola
KO
|
+$210K |
| 5 |
Apple
AAPL
|
+$166K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.96% |
| 2 | Healthcare | 15.13% |
| 3 | Consumer Staples | 14.14% |
| 4 | Communication Services | 11.02% |
| 5 | Consumer Discretionary | 6.35% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
26
Chevron
CVX
$382B
| $1.4M | 1.07% |
9,665
| – | – |
|
27
Nike
NKE
$64.5B
| $1.14M | 0.88% |
15,131
-100
| -0.7% | -$7.86K |
|
28
Roper Technologies
ROP
$40.4B
| $1.12M | 0.86% |
2,150
| – | – |
|
29
State Street SPDR S&P Biotech ETF
XBI
$10.2B
| $1.11M | 0.85% |
12,300
| – | – |
|
30
Verizon
VZ
$202B
| $1.09M | 0.84% |
27,267
-447
| -2% | -$18.9K |
|
31
Realty Income
O
$61B
| $1.06M | 0.81% |
19,780
-1,150
| -5% | -$67K |
|
32
Northrop Grumman
NOC
$77.2B
| $1.03M | 0.79% |
2,190
| – | – |
|
33
Portland General Electric
POR
$5.85B
| $1.02M | 0.78% |
23,314
| – | – |
|
34
General Dynamics
GD
$105B
| $983K | 0.75% |
3,730
| – | – |
|
35
Flowers Foods
FLO
$1.58B
| $896K | 0.69% |
43,350
-2,275
| -5% | -$50K |
|
36
UnitedHealth
UNH
$387B
| $887K | 0.68% |
1,754
| – | – |
|
37
PepsiCo
PEP
$196B
| $887K | 0.68% |
5,830
-100
| -2% | -$16.4K |
|
38
Colgate-Palmolive
CL
$74.7B
| $859K | 0.66% |
9,450
| – | – |
|
39
3M
MMM
$92.7B
| $826K | 0.63% |
6,400
| – | – |
|
40
Intel
INTC
$435B
| $782K | 0.6% |
39,006
-400
| -1% | -$9.02K |
|
41
Paychex
PAYX
$43.8B
| $774K | 0.59% |
5,520
| – | – |
|
42
Becton Dickinson
BDX
$46.4B
| $765K | 0.59% |
3,373
| – | – |
|
43
Trade Desk
TTD
$9.08B
| $705K | 0.54% |
6,000
| – | – |
|
44
Qualcomm
QCOM
$172B
| $649K | 0.5% |
4,223
| – | – |
|
45
Avery Dennison
AVY
$12.8B
| $629K | 0.48% |
3,360
| – | – |
|
46
Fastenal
FAST
$54.9B
| $575K | 0.44% |
16,000
| – | – |
|
47
Church & Dwight Co
CHD
$23.6B
| $544K | 0.42% |
5,200
| – | – |
|
48
Shell
SHEL
$245B
| $516K | 0.4% |
8,236
| – | – |
|
49
Meta Platforms (Facebook)
META
$1.51T
| $515K | 0.39% |
880
| – | – |
|
50
Bristol-Myers Squibb
BMY
$130B
| $503K | 0.39% |
8,900
| – | – |
|
Similar funds
FP
TC
PBRA
DFS
LDNAM
LPAM
CI
ACA
Broadwater Capital's Q4 2024 Portfolio in Review
As of Q4 2024, Broadwater Capital held 241 positions worth $131M, down 3.8% from $136M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Trading was light in Q4 2024: portfolio turnover was 4.6%. Broadwater Capital opened 3 new positions and exited 8, leaving the 241-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 30% of assets, up from 29% a quarter earlier, followed by Healthcare and Consumer Staples.
- Broadwater Capital's largest Q4 2024 buy was Vanguard S&P 500 ETF: 20 shares worth $10.8K.
- Broadwater Capital added most to JPMorgan Chase in Q4 2024, an estimated $303K increase.
- Broadwater Capital's biggest Q4 2024 reduction was CVS Health, cutting an estimated $312K.
- Broadwater Capital fully exited Avangrid, Inc. in Q4 2024, selling an estimated $215K.
- Broadwater Capital's ten largest holdings make up 49% of its $131M portfolio in Q4 2024.
- Broadwater Capital opened 3 new positions and closed 8 in Q4 2024.
- Broadwater Capital's portfolio value fell 3.8% quarter-over-quarter to $131M.
Based on Broadwater Capital's 13F filing for Q4 2024, filed 31 Oct 2025.